Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of Medical Virology|August 31, 2022
Association of viral load with TRAIL, IP-10, CRP biomarker signature and disease severity in children with respiratory tract infection or fever without source: A prospective, multicentre cohort studyCihan Papan, Alberto Argentiero, Ortwin Adams, et al.
European Journal of Pediatrics|November 29, 2022
Use of music therapy in pediatric oncology: an Italian AIEOP multicentric survey study in the era of COVID-19Filippo Giordano, Paola Muggeo, Chiara Rutigliano, et al.
Bone Marrow Transplantation|January 25, 2024
Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP)Federica Galaverna, Francesco Baccelli, Daniele Zama, et al.
Cancer Medicine|August 4, 2016
Abdomen/pelvis computed tomography in staging of pediatric Hodgkin Lymphoma: is it always necessary?Piero Farruggia, Giuseppe Puccio, Alessandra Sala, et al.
Journal of Pediatric Hematology/Oncology|December 30, 2025
Diagnostic Delay and Survival in Pediatric Rhabdomyosarcoma: Is Time a Critical Factor?Maria C Affinita, Stefano Chiaravalli, Giuseppe M Milano, et al.
Mycoses|July 23, 2020
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study)Anna Candoni, Francesca Farina, Katia Perruccio, et al.
American Journal of Hematology|July 20, 2019
A bronchoalveolar lavage-driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM groupFrancesco Marchesi, Chiara Cattaneo, Marianna Criscuolo, et al.
Blood|February 5, 2011
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantationMauro Di Ianni, Franca Falzetti, Alessandra Carotti, et al.
Haematologica|February 27, 2025
<i>Ex vivo</i> drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with <i>PICALM::MLLT10</i>Elena Mastrodicasa, Luca Pagliaro, Valentina Pierini, et al.
Pediatric Blood & Cancer|June 3, 2022
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life studyDavide Massano, Elisa Carraro, Lara Mussolin, et al.
Pageof 9